mitotane has been researched along with thyroxine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cheban, AK; Kommisarenko, IV; Luchitskiĭ, EV; Slavnov, VN | 1 |
| Watson, AD | 1 |
| Appelqvist, P; Kostianinen, S | 1 |
| Bleicher, SJ; Herrera, A; Jubay, F; Kukar, NM; Sacerdote, A | 1 |
| Malik, R; Swinney, GR | 1 |
| Ambrosio, MR; Carandina, G; Daffara, F; Degli Uberti, EC; Gentilin, E; Reimondo, G; Tagliati, F; Terzolo, M; Zatelli, MC | 1 |
| Cannavò, S; Cotta, OR; Frasca, F; Gullo, D; Pellegriti, G; Russo, M; Scollo, C; Squatrito, S | 1 |
3 review(s) available for mitotane and thyroxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Bioavailability and bioinequivalence of drug formulations in small animals.
Topics: Animals; Aspirin; Biological Availability; Cats; Chloramphenicol; Digoxin; Dogs; Fenbendazole; Mitotane; Oxytetracycline; Penicillins; Phenytoin; Theophylline; Therapeutic Equivalency; Thyroxine | 1992 |
Multiple thoracotomy combined with chemotherapy in metastatic adrenal cortical carcinoma: a case report and review of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Carcinoma; Cortisone; Cushing Syndrome; Drug Therapy, Combination; Female; Fludrocortisone; Humans; Lung Neoplasms; Mitotane; Pneumonectomy; Postoperative Care; Radiotherapy Dosage; Thyroxine | 1983 |
6 other study(ies) available for mitotane and thyroxine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Hypothalamo-hypophyseal-thyroid relationship in patients with Itsenko-Cushing disease treated with chloditan].
Topics: Adolescent; Adult; Cushing Syndrome; Female; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Mitotane; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1978 |
Mitotane and low thyroxine levels.
Topics: Humans; Mitotane; Thyroxine; Thyroxine-Binding Proteins | 1981 |
Intermittent heart block in a lethargic dog.
Topics: Adrenocortical Hyperfunction; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Electrocardiography; Female; Heart Block; Hypothyroidism; Mitotane; Thyroxine | 1998 |
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Survival; Enzyme-Linked Immunosorbent Assay; Humans; Mice; Mitotane; Reverse Transcriptase Polymerase Chain Reaction; Thyrotrophs; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 2010 |
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Antineoplastic Agents, Hormonal; Female; Humans; Hypothyroidism; Middle Aged; Mitotane; Retrospective Studies; Thyroid Function Tests; Thyrotropin; Thyroxine; Triiodothyronine | 2016 |